Phase I Dose Escalation Safety Study of RetinoStat in Advanced Age-Related Macular Degeneration (AMD)

NCT01301443 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Age Related Macular Degeneration

Interventions

DRUG: Subretinally injected RetinoStat

Sponsor

Oxford BioMedica